NeoGenomics, Inc.
US ˙ NasdaqCM ˙ US64049M2098

SecurityNEO / NeoGenomics, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership190,456 shares
Latest Disclosed Value $ 1,413,183
UBS Group AG ownership in NEO / NeoGenomics, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 190,456 shares of NeoGenomics, Inc. (US:NEO) valued at $1,413,184 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 347,574 shares of NeoGenomics, Inc.. This represents a change in shares of -45.20% during the quarter. The current value of the position is $2,154,057 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (NEO) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

NEO / NeoGenomics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F NEOGENOMICS COM NEW 64049M209 190,456 -157,118 -45.20 1,413 -65.43 0.0000
2026-01-29 2025-12-31 13F NEOGENOMICS COM NEW 64049M209 347,574 -456,676 -56.78 4,087 -34.17 0.0007
2025-11-13 2025-09-30 13F NEOGENOMICS COM NEW 64049M209 804,250 428,445 114.01 6,209 125.99 0.0010
2025-08-14 2025-06-30 13F NEOGENOMICS COM NEW 64049M209 375,805 -122,516 -24.59 2,747 -41.91 0.0005
2025-05-13 2025-03-31 13F NEOGENOMICS COM NEW 64049M209 498,321 71,921 16.87 4,729 -32.70 0.0009
2025-02-14 2024-12-31 13F NEOGENOMICS COM NEW 64049M209 426,400 287,766 207.57 7,027 243.79 0.0013
2024-11-14 2024-09-30 13F NEOGENOMICS COM NEW 64049M209 138,634 63,612 84.79 2,045 96.54 0.0004
2024-08-14 2024-06-30 13F NEOGENOMICS COM NEW 64049M209 75,022 -3,431 -4.37 1,041 -15.65 0.0003
2024-05-13 2024-03-31 13F NEOGENOMICS COM NEW 64049M209 78,453 -25,674 -24.66 1,233 -26.78 0.0003
2024-02-09 2023-12-31 13F NEOGENOMICS COM NEW 64049M209 104,127 70,693 211.44 1,685 309.73 0.0005
2023-11-09 2023-09-30 13F NEOGENOMICS COM NEW 64049M209 33,434 -85,096 -71.79 411 -78.41 0.0001
2023-08-11 2023-06-30 13F NEOGENOMICS COM NEW 64049M209 118,530 30,850 35.18 1,905 24.77 0.0006
2023-05-12 2023-03-31 13F NEOGENOMICS COM NEW 64049M209 87,680 7,088 8.79 1,527 105.11 0.0006
2023-02-08 2022-12-31 13F NEOGENOMICS COM NEW 64049M209 80,592 42,815 113.34 745 128.92 0.0003
2022-11-10 2022-09-30 13F NEOGENOMICS COM NEW 64049M209 37,777 8,238 27.89 325 34.85 0.0001
2022-08-10 2022-06-30 13F NEOGENOMICS COM NEW 64049M209 29,539 -22,430 -43.16 241 -61.87 0.0001
2022-05-16 2022-03-31 13F NEOGENOMICS COM NEW 64049M209 51,969 -31,506 -37.74 632 -77.81 0.0002
2022-02-14 2021-12-31 13F NEOGENOMICS COM NEW 64049M209 83,475 693 0.84 2,848 -28.68 0.0008
2021-11-15 2021-09-30 13F NEOGENOMICS COM NEW 64049M209 82,782 42,913 107.64 3,993 121.71 0.0013
2021-08-13 2021-06-30 13F NEOGENOMICS COM NEW 64049M209 39,869 -35,214 -46.90 1,801 -50.26 0.0006
2021-05-12 2021-03-31 13F NEOGENOMICS COM NEW 64049M209 75,083 -41,037 -35.34 3,621 -42.08 0.0012
2021-02-11 2020-12-31 13F NEOGENOMICS COM NEW 64049M209 116,120 37,210 47.15 6,252 114.77 0.0021
2020-11-12 2020-09-30 13F NEOGENOMICS COM NEW 64049M209 78,910 -15,619 -16.52 2,911 -0.61 0.0011
2020-07-31 2020-06-30 13F NEOGENOMICS COM NEW 64049M209 94,529 -26,322 -21.78 2,929 -12.23 0.0012
2020-05-01 2020-03-31 13F NEOGENOMICS COM NEW 64049M209 120,851 -26,676 -18.08 3,337 -22.67 0.0016
2020-02-14 2019-12-31 13F NEOGENOMICS COM NEW 64049M209 147,527 58,090 64.95 4,315 152.34 0.0015
2019-11-14 2019-09-30 13F NEOGENOMICS COM NEW 64049M209 89,437 28,079 45.76 1,710 27.04 0.0007
2019-08-14 2019-06-30 13F NEOGENOMICS COM NEW 64049M209 61,358 26,332 75.18 1,346 87.73 0.0005
2019-05-14 2019-03-31 13F NEOGENOMICS COM NEW 64049M209 35,026 -15,399 -30.54 717 12.74 0.0003
2019-02-14 2018-12-31 13F NEOGENOMICS COM NEW 64049M209 50,425 12,231 32.02 636 8.35 0.0003
2018-11-14 2018-09-30 13F NEOGENOMICS COM NEW 64049M209 38,194 3,210 9.18 587 27.89 0.0002
2018-08-14 2018-06-30 13F NEOGENOMICS COM NEW 64049M209 34,984 7,983 29.57 459 108.64 0.0002
2018-05-15 2018-03-31 13F NEOGENOMICS COM NEW 64049M209 27,001 -10,437 -27.88 220 -33.53 0.0001
2018-02-14 2017-12-31 13F NEOGENOMICS COM NEW 64049M209 37,438 2,479 7.09 331 -14.91 0.0001
2017-11-14 2017-09-30 13F NEOGENOMICS COM NEW 64049M209 34,959 1,310 3.89 389 28.81 0.0002
2017-11-14 2017-06-30 13F/A-1 NEOGENOMICS COM NEW 64049M209 33,649 12,604 59.89 302 80.84 0.0002
2017-08-14 2017-06-30 13F NEOGENOMICS COM NEW 64049M209 33,649 12,604 302
2017-11-14 2017-03-31 13F/A-1 NEOGENOMICS COM NEW 64049M209 21,045 -14,965 -41.56 167 -45.95 0.0001
2017-05-12 2017-03-31 13F NEOGENOMICS COM NEW 64049M209 21,045 -14,965 167
2017-02-14 2016-12-31 13F NEOGENOMICS COM NEW 64049M209 36,010 22,200 160.75 309 173.45 0.0002
2016-11-14 2016-09-30 13F NEOGENOMICS COM NEW 64049M209 13,810 760 5.82 113 7.62 0.0001
2016-08-12 2016-06-30 13F NEOGENOMICS COM NEW 64049M209 13,050 1,100 9.21 105 29.63 0.0001
2016-05-12 2016-03-31 13F NEOGENOMICS COM NEW 64049M209 11,950 0 0.00 81 -13.83 0.0001
2016-02-16 2015-12-31 13F NEOGENOMICS COM NEW 64049M209 11,950 -2,500 -17.30 94 13.25 0.0001
2015-11-13 2015-09-30 13F NEOGENOMICS COM NEW 64049M209 14,450 9,275 179.23 83 196.43 0.0001
2015-08-14 2015-06-30 13F NEOGENOMICS COM NEW 64049M209 5,175 1,050 25.45 28 47.37 0.0000
2015-05-14 2015-03-31 13F NEOGENOMICS COM NEW 64049M209 4,125 4,000 3,200.00 19 1,800.00 0.0000
2015-02-17 2014-12-31 13F NEOGENOMICS COM NEW 64049M209 125 125 1 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-08-14 2024-06-30 13F NEOGENOMICS COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-13 2024-03-31 13F NEOGENOMICS COM NEW Call 46,100 725 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.